Hyaluronic Acid Supplements Recalled for Potential Undeclared Pharmaceutical Contaminants
MXBBB is recalling hyaluronic acid caplets after notification that product may contain undeclared diclofenac and omeprazole. No analytical confirmation of contamination has been found, but the firm is recalling out of precaution.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or confirmed contamination. However, the potential presence of undeclared prescription drugs (diclofenac and omeprazole) in a dietary supplement represents a clear risk of serious harm including adverse drug effects and interactions, justifying a High severity rating despite the lack of analytical confirmation.
Plain-English summary
MXBBB is recalling 321 bottles of UMARY ACID HYALURONIC 850 MG CAPLETS (UPC 7502265120323, Lot 24183, expiration 07/01/28) sold via Amazon Marketplace. The recall was initiated after the firm received notification from its distributor that product may be tainted with undeclared diclofenac and omeprazole.
Diclofenac is a prescription nonsteroidal anti-inflammatory drug (NSAID) and omeprazole is a prescription proton pump inhibitor. Consumers purchasing hyaluronic acid supplements should not be exposed to these pharmaceutical ingredients unknowingly. The undeclared drugs could pose serious health risks, including adverse effects and harmful drug interactions, particularly in individuals taking other medications or with underlying health conditions.
Notably, no analytical testing by the firm has confirmed the presence of these contaminants in distributed product. Consumers who have purchased this product should stop use and may contact MXBBB for further information. If anyone has experienced adverse health effects after using this product, they should contact their healthcare provider and may report the incident to the FDA.
The recalled product
- Product
- UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323
- Manufacturer
- MXBBB
- Category
- Drug — Dietary Supplement
- Hazard
- undeclared-pharmaceutical
- drug-interaction-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: 24183
- Exp 07/01/28
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27